Cargando…
Acute Kidney Injury Associated with Linagliptin
Linagliptin is a dipeptidyl peptidase-IV (DPP-IV) inhibitor that is approved for the treatment of type 2 diabetes mellitus. About 5% of linagliptin is eliminated by the kidneys and no dose adjustment is recommended in kidney impairment. We report a first case of linagliptin-associated acute kidney i...
Autores principales: | Nandikanti, Deepak K., Gosmanova, Elvira O., Gosmanov, Aidar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769737/ https://www.ncbi.nlm.nih.gov/pubmed/26981294 http://dx.doi.org/10.1155/2016/5695641 |
Ejemplares similares
-
Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function
por: Nguyen, Son, et al.
Publicado: (2020) -
Management of adult diabetic ketoacidosis
por: Gosmanov, Aidar R, et al.
Publicado: (2014) -
Methimazole-Induced Goitrogenesis in an Adult Patient With the Syndrome of Resistance to Thyroid Hormone
por: Glymph, Kathleen, et al.
Publicado: (2014) -
Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy
por: Schumacher, Kamilya A., et al.
Publicado: (2022) -
ODP048 Large Bilateral Adrenal Lesions Abutting Right Hemidiaphragm in a Man from Texas
por: Gosmanova, Albina, et al.
Publicado: (2022)